Evidence map›Paper›PMID 30938472›Full record

ArticleJournal of clinical laboratory analysis2019

Serum amylase activity altered by the ABO blood group system in Chinese subjects.

You-Fan Peng, Hemant Goyal, Hao Lin, De-Chen Liu, Ling Li

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

You-Fan PengDepartment of Endocrinology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China.
Hemant GoyalDepartment of Internal Medicine, School of Medicine, Mercer University, Macon, Georgia, USA.
Hao LinPancreatic Research Institute, Southeast University, Nanjing, China.
De-Chen LiuPancreatic Research Institute, Southeast University, Nanjing, China.
Ling LiDepartment of Endocrinology, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China.ORCID https://orcid.org/0000-0002-7894-8251
Zhongda Hospital Southeast University · CNMercer University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe underlying interactions between ABO blood group antigens and pancreatic exocrine tissue have been demonstrated, and serum amylase was synthesized by pancreatic ductal cells. Thus, we investigated the link between ABO blood type and serum amylase activity in Chinese subjects.

methodsOur study included 343 relatively healthy Chinese individuals, and the data were retrieved from electronic medical record database.

resultsA increased trend was observed for serum amylase activity in ABO blood type distribution, and we found that serum amylase activity was remarkable increased in subjects with O blood type compared to those with non-O blood type (P = 0.013). Logistic regression analysis indicated that serum amylase was independently associated with individuals with O blood group (adjusted odds ratio 1.574; 95% CI, 1.022-2.425, P = 0.039).

conclusionsThe present evidence suggests a significant link between serum amylase activity and ABO blood type in the study population, indicating ABO blood type may be associated with the susceptibility of pancreatic disease.

Indexed as

ABO Blood-Group SystemAdolescentAdultAmylasesAsian PeopleFemaleHumansLogistic ModelsMaleMiddle AgedPancreatic alpha-AmylasesRetrospective StudiesABO Blood-Group SystemAmylasesPancreatic alpha-AmylasesABO blood typeChinese subjectsSerum amylase

Identifiers

PMID30938472
PMCPMC6595472
OpenAlexW2928322278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.